These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Brain tryptophan perturbation in hepatic encephalopathy: implications for effects by neuropsychoactive drugs in clinical practice. Bengtsson F; Bergqvist PB; Apelqvist G Adv Exp Med Biol; 1997; 420():1-33. PubMed ID: 9286423 [No Abstract] [Full Text] [Related]
7. Analysis of hospitalizations comparing rifaximin versus lactulose in the management of hepatic encephalopathy. Neff GW; Kemmer N; Zacharias VC; Kaiser T; Duncan C; McHenry R; Jonas M; Novick D; Williamson C; Hess K; Thomas M; Buell J Transplant Proc; 2006 Dec; 38(10):3552-5. PubMed ID: 17175328 [TBL] [Abstract][Full Text] [Related]
8. Assessment and usefulness of clinical scales for semiquantification of overt hepatic encephalopathy. Sakamoto M; Perry W; Hilsabeck RC; Barakat F; Hassanein T Clin Liver Dis; 2012 Feb; 16(1):27-42. PubMed ID: 22321463 [TBL] [Abstract][Full Text] [Related]
9. Neuropsychiatric condition must be thoroughly assessed before treatment of hepatic encephalopathy. Lewis MB BMJ; 1999 Aug; 319(7207):455. PubMed ID: 10445943 [No Abstract] [Full Text] [Related]
10. Minimal hepatic encephalopathy: time to recognise and treat. Dhiman RK; Chawla YK Trop Gastroenterol; 2008; 29(1):6-12. PubMed ID: 18564660 [TBL] [Abstract][Full Text] [Related]
11. Paroxystic neuropsychological symptoms as the early expression of hepatic encephalopathy. A case report. Abts H; Crols R; Mariën P; Saerens J; Holvoet J; de Deyn P Acta Neurol (Napoli); 1993 Aug; 15(4):268-76. PubMed ID: 8249670 [TBL] [Abstract][Full Text] [Related]
13. Pharmacoeconomics of hepatic encephalopathy. Neff G Pharmacotherapy; 2010 May; 30(5 Pt 2):28S-32S. PubMed ID: 20412038 [TBL] [Abstract][Full Text] [Related]
14. [The imminent peril in the law of July the fifth 2011, two years later: the impact on health?]. Mondoloni A; Buard M; Nargeot J; Vacheron MN Encephale; 2014 Dec; 40(6):468-73. PubMed ID: 24703930 [TBL] [Abstract][Full Text] [Related]
15. Accuracy of the initial diagnosis among patients with an acutely altered mental status. Sporer KA; Solares M; Durant EJ; Wang W; Wu AH; Rodriguez RM Emerg Med J; 2013 Mar; 30(3):243-6. PubMed ID: 22362650 [TBL] [Abstract][Full Text] [Related]
16. [Follow-up discussion on restructuring the medical-service system]. Kato S; Kamada A Kekkaku; 2012 Dec; 87(12):809-19. PubMed ID: 23350522 [TBL] [Abstract][Full Text] [Related]
17. Altered consciousness in Ugandan hospital admissions. Rwebembera J; Wilson T Trop Doct; 2009 Oct; 39(4):240-1. PubMed ID: 19762582 [TBL] [Abstract][Full Text] [Related]
18. [Reduction of hospital stay with the use of L-ornithine L-aspartate (LOLA) in patients with hepatic encephalopathy]. Abdo-Francis JM; Pérez-Hernández JL; Hinojosa-Ruiz A; Hernández-Vásquez JR Rev Gastroenterol Mex; 2010; 75(2):135-41. PubMed ID: 20615780 [TBL] [Abstract][Full Text] [Related]
19. Increased risk of cognitive impairment in cirrhotic patients with bacterial infections. Merli M; Lucidi C; Pentassuglio I; Giannelli V; Giusto M; Di Gregorio V; Pasquale C; Nardelli S; Lattanzi B; Venditti M; Riggio O J Hepatol; 2013 Aug; 59(2):243-50. PubMed ID: 23523580 [TBL] [Abstract][Full Text] [Related]
20. Rifaximin for the treatment of hepatic encephalopathy. Mantry PS; Munsaf S Transplant Proc; 2010 Dec; 42(10):4543-7. PubMed ID: 21168733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]